Ушбу ишга иқтибос қилган ишлар

4 та иш

Иш: The molecular biology and therapeutic potential of Nrf2 in leukemia

1. Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds

   Mohammed H. Mohammed, Raed Fanoukh Aboqader Al-Aouadi, Subasini Uthirapathy +7

   Шарҳ мақолаHistone Deacetylase Inhibitors ResearchNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000155

2. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768

3. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

   Qamar Abuhassan, Ali M Atoom, M.M. Rekha +5

   МақолаPsoriasis: Treatment and PathogenesisHuman Immunology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.004934

4. Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

   Qamar Abuhassan, Hamzeh J. Al‐Ameer, Hani Moslem Ahmed +4

   МақолаCancer, Hypoxia, and MetabolismIUBMB Life20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013100